Thuja Capital is an early-stage venture capital firm that is aimed at building and scaling companies with a prime focus on therapeutics and medical devices.
Thuja Capital typically invests in private healthcare companies in the space of biotech, nutraceuticals, medtech and digital health. Often these companies have a specific product that requires clinical validation and is defendable. Thuja values credible business models with a global reach.
They invest in product focused companies that aim to have true impact for patients and doctors alike, as demonstrated in clinical studies to enable a health claim. Hence most of theri ventures are active in the field of therapeutics, medical devices and digital health. They also take an active role in helping the company to become successful, by leveraging their extensive network and by bringing their own experience to the table.